| Active Pharmaceutical Ingredients (API) | Development and manufacture of diverse APIs and advanced intermediates for regulated and non-regulated markets. | US FDA and EU GMP approvals; in-house R&D; backward integration capabilities. | Pharmaceutical companies (B2B) in regulated and non-regulated markets. | Specialized sterile carbapenems and niche intermediates. | 330 | 54 | Sales of bulk drugs to pharmaceutical manufacturers globally. | Contract and spot sales with negotiated pricing based on volume and market conditions. | High global demand for antibiotics and specialized APIs; focus on reducing China dependence. | Atenolol, Sterile Carbapenems, Cephalosporins, Macrolides |
| Pharmaceutical Formulations | Manufacture and export of oral solid, liquid, and suspension dosage forms including penicillin and non-penicillin drugs. | Strong international approvals, dedicated manufacturing facilities, and supply chain experience. | Global pharmaceutical distributors and healthcare providers (B2B). | Penicillin-based oral dosage forms. | 279 | 45 | Export sales under contract and tender-based supply agreements. | Export contracts, tenders, and repeat orders with negotiated terms. | Product innovation, increasing global demand for oral dosage forms, and regulatory certifications. | SMYLE |
